FUJIF - FUJIFILM Holdings Corporation

Other OTC - Other OTC 延遲價格。貨幣為 USD。
0.00 (0.00%)
收市:03:25PM EDT
買盤無 x 無
賣出價無 x 無
今日波幅60.00 - 60.00
52 週波幅45.26 - 61.36
Beta 值 (5 年,每月)0.39
市盈率 (最近 12 個月)16.17
每股盈利 (最近 12 個月)3.71
遠期股息及收益率1.04 (1.73%)
1 年預測目標價
  • Insider Monkey

    16 Largest Photography Companies In The World

    In this article, we will take a look at the 16 largest photography companies in the world. If you want to see more companies in this selection, go to the 5 Largest Photography Companies in the World. According to Zion Market Research, the size of the global digital photography market stood at $105.2 billion at […]

  • Benzinga

    Once Favored By Late Shinzo Abe, Japan Culls Development On Repurposed COVID-19 Treatment

    Fujifilm Holdings Corp (OTC: FUJIY) (OTC: FUJIF) has discontinued the development of its anti-influenza drug, Avigan (favipiravir), for use as a therapeutic drug against COVID-19. In 2021, Fujifilm Toyama Chemical began a phase 3 clinical trial in Japan with a target enrollment of 316 subjects to confirm Avigan's efficacy in preventing the progression to severe symptoms in COVID-19 patients who have not yet been vaccinated. However, enrollment was terminated at 84 subjects in March 2022 followin